methylene blue is currently approved for the treatment of numerous conditions, of which include acquired and hereditary methemoglobinemia, preventing ifosfamide-induced encephalopathy in cancer patients, preventing urinary tract infections, visualizing nerves and endocrine glands during surgical procedures, and sterilizing blood prior to transfusions.
Overview
- Condition: New
Features:
- Its ability to mitigate inflammation and shield cells from damage helps prevent chronic diseases linked to prolonged oxidative stress.
